MBNGT

Active not recruitingPhase NA

Mindfulness-Based Nutrition Group Therapy as an Adjunct to GLP-1 Treatment of Obesity

Lead sponsor

Bern University of Applied Sciences

Asset

GLP-1 / incretin class catch-all

Listed sites

Recruiting sites

Estimated enrollment

Study population

Obesity / overweight

Eligibility highlights

Primary endpoints

•Recruitment rate•Retention rate•Adherence

Registered trial locations

Locations reported to ClinicalTrials.gov for this trial snapshot. Site count is not enrollment count; per-site enrollment is not available from source.

Identifiers

Registered as

NCT IDNCT07649759

Org study ID01654342

Timeline

Milestones

Study start2026-02-01actual

Study first posted2026-06-16actual

Last update posted2026-06-16actual

Primary completion2026-08estimated (month precision)

Study completion2027-08estimated (month precision)

Assets

Investigational agents

GLP-1 / incretin class catch-all

Who this study enrolls

Obesity / overweight

Who can enroll

Minimum age18 Years

SexAll

Healthy volunteersNot accepted

Inclusion criteria

•Adults aged ≥18

•Use of GLP-1-RAs for ≥ 4 months

•Ability to provide informed consent

•Sufficient German language proficiency to participate in group sessions and complete questionnaires

•Willingness and ability to participate in a 16-week program and attend follow-up assessments

Exclusion criteria

•Pregnant or lactating women

•Diagnosed substance use disorders (e.g., alcohol)

•Diagnosed severe psychiatric disorders (e.g., psychosis, acute major depression, binge-eating-disorder)

•Medical contraindications that prevent participation in behavioral interventions (e.g., unstable chronic disease)

•Current participation in another behavioral or weight-related intervention study

•Cognitive impairment or language barriers that prevent meaningful participation

Endpoints (21)

What's being measured

Protocol endpoints and posted registry outcome measures, grouped into outcome categories. Composite endpoints show their component event types. Standard codes (LOINC, SNOMED CT) are shown where available.

Coverage by outcome category

Other (unclassified)

Patient-reported / QoL

Other clinical outcomes

Weight & body composition

1 endpoint

Other/protocol endpoint

Weight Bias Internalization Scale (WBIS-M)

Time frame:At week 16 and twelve-months follow-up

descriptive

Patient-reported / QoL

6 endpoints

Primary/protocol endpoint

Completeness of questionnaire data

Time frame:At baseline and week 16 (±2-weeks)

descriptive

Other/protocol endpoint

Dutch Eating Behaviour Questionnaire

Time frame:At week 16 and twelve-months follow-up

descriptive

Other/protocol endpoint

Five Facet Mindfulness Questionnaire (FFMQ)

Time frame:At week 16 and twelve-months follow-up

descriptive

Other/protocol endpoint

Appearance-related quality of life and functioning (BODY-Q)

Time frame:At week 16 and twelve-months follow-up

descriptive

Other/protocol endpoint

EuroQol 5 Dimensions (EQ-5D)

Time frame:At week 16 and twelve-months follow-up

descriptive

Other/protocol endpoint

Self-Regulation of Eating Behavior Questionnaire (SREBQ)

Time frame:At week 16 and twelve-months follow-up

descriptive

Other clinical outcomes

3 endpoints

Primary/protocol endpoint

Retention rate

Time frame:From randomization to week 16 (±2-weeks)

descriptive

Primary/protocol endpoint

Adherence

Time frame:At week 16 (±2-weeks)

descriptive

Other/protocol endpoint

Standardized Self-Report Measure of Emotional Competence (SEK-27)

Time frame:At week 16 and twelve-months follow-up

descriptive

Other (unclassified)

11 endpoints

Primary/protocol endpoint/low confidence

Recruitment rate

Time frame:From start of recruitment to completion of recruitment

descriptive

Primary/protocol endpoint/low confidence

Acceptability of the intervention

Time frame:At week 16 (±2-weeks)

descriptive

Primary/protocol endpoint/low confidence

Session Attendance

Time frame:At week 16 (±2-weeks)

descriptive

Primary/protocol endpoint/low confidence

Randomization Acceptance and Attrition

Time frame:At week 16 (±2-weeks)

descriptive

Other/protocol endpoint/low confidence

Mindful Eating Inventory (MEI)

Time frame:At week 16 and twelve-months follow-up

descriptive

Other/protocol endpoint/low confidence

Big Five Inventory-10 (BFI-10)

Time frame:At week 16 and twelve-months follow-up

descriptive

Other/protocol endpoint/low confidence

Impulsive Behavior-8 Scale (I-8)

Time frame:At week 16 and twelve-months follow-up

descriptive

Other/protocol endpoint/low confidence

PERMA-Profiler

Time frame:At week 16 and twelve-months follow-up

descriptive

Other/protocol endpoint/low confidence

Depression Anxiety Stress Scales (DASS-21)

Time frame:At week 16 and twelve-months follow-up

descriptive

Other/protocol endpoint/low confidence

Self-Compassion Scale (SCS-D)

Time frame:At week 16 and twelve-months follow-up

descriptive

Other/protocol endpoint/low confidence

Body Appreciation Scale-2

Time frame:At week 16 and twelve-months follow-up

descriptive

Provenance

Sources

Trial identity, design, statusClinicalTrials.gov API v2

Snapshot dateJuly 6, 2026

Endpoint classificationDelfa endpoint taxonomy v2 (May 13, 2026)

Results tableno registry results posted yet

Trial facts come from public ClinicalTrials.gov records. Endpoint categories are Delfa's classification of those records, not a ClinicalTrials.gov field. All figures reflect the July 6, 2026 snapshot.